Notably, no significant differences were observed between high and low TRIM6 expression for other common AML chemotherapeutics, such as all-trans retinoic acid, cytarabine, and cisplatin (S1 Fig). The gene discussed is TRIM6; the disease is acute myeloid leukemia.